Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
74.2M
-
Number of holders
-
52
-
Total 13F shares, excl. options
-
19.6M
-
Shares change
-
+304K
-
Total reported value, excl. options
-
$23.5M
-
Value change
-
+$589K
-
Number of buys
-
23
-
Number of sells
-
-19
-
Price
-
$1.20
Significant Holders of ENZON PHARMACEUTICALS, INC. - Common Stock, par value $0.01 per share (ENZN) as of Q2 2015
58 filings reported holding ENZN - ENZON PHARMACEUTICALS, INC. - Common Stock, par value $0.01 per share as of Q2 2015.
ENZON PHARMACEUTICALS, INC. - Common Stock, par value $0.01 per share (ENZN) has 52 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.6M shares
of 74.2M outstanding shares and own 26.36% of the company stock.
Largest 10 shareholders include ICAHN CARL C (5.9M shares), RENAISSANCE TECHNOLOGIES LLC (3.61M shares), BlackRock Institutional Trust Company, N.A. (2.88M shares), VANGUARD GROUP INC (1.4M shares), BlackRock Advisors LLC (746K shares), UBS Group AG (708K shares), Ativo Capital Management LLC (417K shares), Spark Investment Management LLC (363K shares), Connor, Clark & Lunn Investment Management Ltd. (357K shares), and JACOBS LEVY EQUITY MANAGEMENT, INC (262K shares).
This table shows the top 52 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.